These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7581713)

  • 1. Assay of radiolabeled VIP binding and hydrolysis by antibodies.
    Huang H; Paul S
    Methods Mol Biol; 1995; 51():409-15. PubMed ID: 7581713
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
    Paul S; Volle DJ; Mei S
    J Immunol; 1990 Aug; 145(4):1196-9. PubMed ID: 2380555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of radiolabeled photolabile probes of high specific radioactivity for affinity labeling.
    Miller LJ; Hadac EM; Powers SP
    Anal Biochem; 1994 Aug; 220(2):434-5. PubMed ID: 7978292
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods of measuring thyroglobulin and peptide-methylcoumarinamide hydrolysis by autoantibodies.
    Li L; Kalaga R; Kaveri S; Paul S
    Methods Mol Biol; 1995; 51():417-21. PubMed ID: 7581714
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of monoiodinated vasointestinal peptide (M125I-VIP) by high pressure liquid chromatography (HPLC).
    Marie JC; Boissard C; Rosselin G
    Peptides; 1984; 5(2):179-82. PubMed ID: 6089129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site specificity of a catalytic vasoactive intestinal peptide antibody. An inhibitory vasoactive intestinal peptide subsequence distant from the scissile peptide bond.
    Paul S; Volle DJ; Powell MJ; Massey RJ
    J Biol Chem; 1990 Jul; 265(20):11910-3. PubMed ID: 2365706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.
    Paul S; Volle DJ; Beach CM; Johnson DR; Powell MJ; Massey RJ
    Science; 1989 Jun; 244(4909):1158-62. PubMed ID: 2727702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of highly purified iodinated peptides by high pressure liquid chromatography.
    McMaster D; Rorstad OP; Suzuki Y; Lederis K
    Proc West Pharmacol Soc; 1984; 27():237-41. PubMed ID: 6494161
    [No Abstract]   [Full Text] [Related]  

  • 13. Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies.
    Paul S; Mei S; Mody B; Eklund SH; Beach CM; Massey RJ; Hamel F
    J Biol Chem; 1991 Aug; 266(24):16128-34. PubMed ID: 1874750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical study on tumor vasoactive intestinal peptide receptor scintigraphy.
    Wang X; Zhang M; Yang Z; Lin B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):331-4. PubMed ID: 12408757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    J Biol Chem; 1994 Dec; 269(51):32389-93. PubMed ID: 7798238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometric labeling of peptides by iodination on tyrosyl or histidyl residues.
    Tsomides TJ; Eisen HN
    Anal Biochem; 1993 Apr; 210(1):129-35. PubMed ID: 8489008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic activity of an antibody light chain.
    Sun M; Gao QS; Li L; Paul S
    J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
    Okochi N; Kato-Murai M; Kadonosono T; Ueda M
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
    Igarashi H; Ito T; Mantey SA; Pradhan TK; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2005 Oct; 315(1):370-81. PubMed ID: 15994369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic assay for tryptase based on the hydrolysis of dansyl-vasoactive intestinal peptide.
    Delaria K; Muller D
    Anal Biochem; 1996 Apr; 236(1):74-81. PubMed ID: 8619498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.